UTHR - Financial Reports List - United Therapeutics Corporation - IntrinsicAlpha

United Therapeutics Corporation UTHR

Healthcare - Biotechnology - NASDAQ - US

$ 284.25

-0.169 %

$ 12.8 B

Market Cap

11.54

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	19.72%	38.78%	37.52%
Annual Report	FY	10-K	2024-12-31	23.63%	21.35%	16.21%
Quarterly Report	Q3	8-K	2024-09-30	22.89%	15.51%	4.92%
Quarterly Report	Q2	8-K	2024-06-30	19.85%	7.29%	2.07%
Quarterly Report	Q1	8-K	2024-03-31	33.70%	27.27%	25.28%
Quarterly Report	Q4	8-K	2023-12-31	25.07%	64.35%	48.12%
Annual Report	FY	10-K	2023-12-31	20.20%	35.40%	20.95%
Quarterly Report	Q3	8-K	2023-09-30	18.10%	11.83%	4.04%
Quarterly Report	Q2	8-K	2023-06-30	27.76%	123.45%	99.87%
Quarterly Report	Q1	8-K	2023-03-31	9.74%	0.42%	-1.25%

1